NCT02759289View on ClinicalTrials.gov

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

CompletedOBSERVATIONAL
Enrollment

279

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 15, 2020

Study Completion Date

September 15, 2020

Conditions
AtherosclerosisType 2 Diabetes (T2D)
Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02759289 - Arsenic, Disordered Glucose Homeostasis and Atherosclerosis | Biotech Hunter | Biotech Hunter